Home > Insider Trading > Filing (0001127602-24-008995)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591312	I Bassil Dahiyat	C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-03-05	12,528	$23.43	300,097	No	4	S	Direct
Common Stock	Acquisiton	2024-03-05	54,538	$0.00	354,635	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Acquisiton	2024-03-05	327,225	$0.00	327,225	$22.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
327,225		2034-03-04	No	4	A	Direct

Footnotes

Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 34,094 restricted stock units.
Includes the following shares acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan: 304 shares acquired in June 2023 and 408 shares acquired in December 2023.
Represents restricted stock units that vest as follows: 1/3 of the shares vest on the first, second and third anniversaries of the date of grant.
25% of the shares subject to the option shall vest on the one year anniversary of March 5, 2024 (the "Vesting Commencement Date") and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.